20 June 2013
Keywords: genentech, nutropin, depot, approved, usa, received, clearance
Article | 29 December 1999
Genentech has received US clearance to market its Nutropin Depot(somatropin [rDNA origin] as an injectable suspension) for pediatric growth ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.